| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman And CMO
1 company
Kim Christopher is a Chairman And CMO at Apimeds Pharmaceuticals US, Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $364K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | APUS Apimeds Pharmaceuticals Us, Inc. | Chairman And CMO | Buy | 27,500 | $1.83 | $50,359.20 | +139.1% | -13.4% | - |